Franklin Resources
AGRX

Franklin Resources’s Agile Therapeutics AGRX Stock Holding History

Franklin Resources’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-306
Closed -$302K – 1553
2018
Q2 		$302K Sell
306
-1,372
-82% -$4.81M ﹤0.01% 1391
2018
Q1 		$8.62M Buy
1,678
+244
+17% +$1.61M ﹤0.01% 948
2017
Q4 		$7.71M Buy
1,434
+48
+3% +$447K ﹤0.01% 995
2017
Q3 		$12.4M Hold
1,386
– – 0.01% 902
2017
Q2 		$10.4M Buy
1,386
+390
+39% +$2.7M 0.01% 938
2017
Q1 		$6.38M Buy
996
+317
+47% +$1.59M ﹤0.01% 1062
2016
Q4 		$7.74M Sell
679
-21
-3% -$294K ﹤0.01% 1019
2016
Q3 		$9.77M Hold
700
– – 0.01% 982
2016
Q2 		$10.7M Hold
700
– – 0.01% 955
2016
Q1 		$8.69M Buy
+700
New +$9.04M ﹤0.01% 1011

Other funds holding AGRX

PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
NIM
Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources's AGRX Position: Q3 2018 in Review

Franklin Resources sold out of Agile Therapeutics (AGRX) in Q3 2018, closing a stake of 306 shares — an estimated $302K sold.

Franklin Resources first reported a position in AGRX in Q1 2016 and held it in 10 quarters. The position peaked at $12.4M in Q3 2017. 29 funds tracked by Wall St. Rank hold AGRX as of Q3 2018.

  • Franklin Resources reported no remaining Agile Therapeutics position as of Q3 2018 after selling out during the quarter.
  • Franklin Resources sold 306 Agile Therapeutics shares in Q3 2018, an estimated $302K.
  • Franklin Resources first reported a position in Agile Therapeutics in Q1 2016 and held it in 10 quarters.
  • Franklin Resources's Agile Therapeutics position peaked at $12.4M in Q3 2017.
  • 29 funds tracked by Wall St. Rank held Agile Therapeutics as of Q3 2018.

Based on Franklin Resources's 13F filing for Q3 2018, filed 13 Nov 2018.